| (1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-2-CHLOROACETYL-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE |
他达拉非中间体 |
171489-59-1 |
| Valdecoxib IMpurity D |
帕瑞昔布钠杂质07 |
181696-35-5 |
| Bortezomib |
硼替佐米 |
179324-69-7 |
| 1-(3-Methoxypropyl)-4-piperidinamine |
1-(3-甲氧基丙基)-4-哌啶胺 |
179474-79-4 |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
(aR,3aS,4S,6S,7aR)-六氢-3a,8,8-三甲基-alpha-(2-甲基丙基)-4,6-甲桥-1,3,2-苯并二氧硼烷-2-甲胺 2,2,2-三氟乙酸盐 |
179324-87-9 |
| (3S)-N-[[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]Methyl]-1-azabicyclo[2.2.2]octan-3-aMine |
(3S)-N-[[(1S)-1,2,3,4-四氢-1-萘基]甲基]-1-氮杂双环[2.2.2]辛烷-3-胺 |
177793-80-5 |
| 7-(3-Chloro-5-(trifluoroMethyl)pyridin-2-yl)-5-Methyl-[1,2,4]triazolo[1,5-a]pyriMidine |
1-[3-氯-5-(三氟甲基)-2-吡啶基]-3-环丙基-1,3-丙二酮 |
172527-65-0 |
| CANGRELOR |
坎格雷洛 |
163706-06-7 |
| cangrelor tetrasodium |
坎格雷洛四钠盐 |
163706-36-3 |
| (2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol |
坎格雷洛中间体 |
163706-58-9 |
| Phosphonic acid, P,P'-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1) |
氯屈膦酸三正丁胺盐 |
163706-61-4 |
| LCZ 696 Impurity C |
LCZ 696杂质C |
149709-63-7 |
| (2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoate |
(2R,4S)-乙基 5-([1,1'-联苯]-4-基)-4-((叔丁氧羰基)氨基)-2-甲基戊酸 |
149709-60-4 |
| Palonosetron Hydrochloride |
盐酸帕洛诺司琼 |
135729-62-3 |
| Valsartan Related Compound A |
缬沙坦相关化合物A |
137862-87-4 |
| 3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸 |
119736-16-2 |
| 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride |
5,6,7,7a-四氢噻吩并[3,2-c]吡啶-2(4H)-酮盐酸盐 |
115473-15-9 |
| N-Benzylhydroxylamine hydrochloride |
N-苄基羟胺盐酸盐 |
29601-98-7 |
| 4-Hydrazinobenzoic acid hydrochloride |
4-羧基苯肼盐酸盐 |
24589-77-3 |
| 6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride |
6,7-二甲氧基-3,4-二氢异喹啉盐酸盐 |
20232-39-7 |
QQ
